Skip to main content

Advertisement

SpringerLink
Log in

Genetic analysis of ADIPOQ variants and gastric cancer risk: a hospital-based case–control study in China

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Single-nucleotide polymorphisms (SNPs) of adiponectin (ADIPOQ), adiponectin receptor 1 (ADIPOR1) and ADIPOR2 genes contribute to the risk and progression of cancers. Here, we investigated the associations between variants of these three genes and the risk of gastric cancer. We genotyped six ADIPOQ SNPs, nine ADIPOR1 SNPs and six ADIPOR2 SNPs using the Sequenom technique in a hospital-based case–control study of patients with gastric cancer and cancer-free controls in the Chinese Han population. We found associations of certain variants with location of gastric cancer. Rs16861205 with the minor allele A in ADIPOQ, rs10773989 with the minor allele C and rs1044471 with the minor allele T in ADIPOR2 presented significant associations with a decreased risk of cardia cancer (P = 0.024, OR 0.605, 95 % CI 0.390–0.938; P = 0.015, OR 0.699, 95 % CI 0.522–0.935; and P = 0.022, OR = 0.703, 95 % CI 0.519–0.951, respectively). ADIPOQ rs16861205 with minor allele A displayed an association with an increased risk of body cancer (P = 0.010, OR 1.821, 95 % CI 1.148–2.890). Further stratified analysis of the patients indicated that there were significant correlations for rs1342387A/G (P = 0.027) and rs16861205A/G (P = 0.000) with tumor location; rs16850799A/G (P = 0.004) and rs2058033C/A (P = 0.003) with invasion depth; rs16850799A/G (P = 0.019) with the tumor-node-metastasis stage; rs16850799A/G (P = 0.016), rs1501299A/C (P = 0.005) and rs1063538C/T (P = 0.017) with alcohol consumption; rs11612414A/G (P = 0.040) and rs12733285T/C (P = 0.005) with salted food; rs1063538C/T (P = 0.043) with family history of gastric cancer; and rs11612414A/G (P = 0.029) with gender. Adiponectin expression significantly correlated with gender (P = 0.014), alcohol consumption (P = 0.037), family history (P = 0.019) and invasion depth of primary tumor (P = 0.024). Our data suggested that variants of ADIPOQ may be genetic markers conferring susceptibility to gastric cancer subtypes. These findings need to be validated in a larger panel of samples from distinct populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.

    Article  PubMed  Google Scholar 

  2. Wex T, Bornschein J, Malfertheiner P. Host polymorphisms of immune regulatory genes as risk factors for gastric cancer. Minerva Gastroenterol Dietol. 2009;55(4):395–408.

    PubMed  CAS  Google Scholar 

  3. Barresi V, Grosso M, Giuffre G, Tuccari G, Barresi G. The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol. 2009;62(8):705–9. doi:10.1136/jcp.2009.066175.

    Article  PubMed  CAS  Google Scholar 

  4. Gonullu G, Kahraman H, Bedir A, Bektas A, Yucel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis. 2010;25(2):205–12. doi:10.1007/s00384-009-0828-6.

    Article  PubMed  Google Scholar 

  5. Barb D, Pazaitou-Panayiotou K, Mantzoros CS. Adiponectin: a link between obesity and cancer. Expert Opin Investig Drugs. 2006;15(8):917–31. doi:10.1517/13543784.15.8.917.

    Article  PubMed  CAS  Google Scholar 

  6. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007;92(3):1041–8. doi:10.1210/jc.2006-1858.

    Article  PubMed  Google Scholar 

  7. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94(9):1221–5. doi:10.1038/sj.bjc.6603051.

    Article  PubMed  CAS  Google Scholar 

  8. Liu L, Zhong R, Wei S, Yin JY, Xiang H, Zou L, et al. Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One. 2011;6(11):e27301. doi:10.1371/journal.pone.0027301.

    Article  PubMed  CAS  Google Scholar 

  9. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, et al. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol. 2010;24(7):1441–52. doi:10.1210/me.2009-0498.

    Article  PubMed  CAS  Google Scholar 

  10. Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP, et al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer. 2008;15(1):289–99. doi:10.1677/ERC-07-0197.

    Article  PubMed  CAS  Google Scholar 

  11. Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, et al. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study. Cancer Causes Control. 2009;20(5):625–33. doi:10.1007/s10552-008-9273-z.

    Article  PubMed  Google Scholar 

  12. Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol. 2008;285(1–2):43–50. doi:10.1016/j.mce.2008.01.023.

    Article  PubMed  CAS  Google Scholar 

  13. Mistry T, Digby JE, Chen J, Desai KM, Randeva HS. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun. 2006;348(3):832–8. doi:10.1016/j.bbrc.2006.07.139.

    Article  PubMed  CAS  Google Scholar 

  14. Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, et al. Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol. 2010;45(9):918–27. doi:10.1007/s00535-010-0228-2.

    Article  PubMed  CAS  Google Scholar 

  15. Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, et al. Prognostic effect of circulating adiponectin in a randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol. 2012;30(2):151–7. doi:10.1200/JCO.2011.35.2237.

    Article  PubMed  CAS  Google Scholar 

  16. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab. 2004;89(3):1160–3.

    Article  PubMed  CAS  Google Scholar 

  17. Lu JP, Hou ZF, Duivenvoorden WC, Whelan K, Honig A, Pinthus JH. Adiponectin inhibits oxidative stress in human prostate carcinoma cells. Prostate Cancer Prostatic Dis. 2012;15(1):28–35. doi:10.1038/pcan.2011.53.

    Article  PubMed  CAS  Google Scholar 

  18. Chen MW, Ye S, Zhao LL, Wang SY, Li YX, Yu CJ, et al. Association of plasma total and high-molecular-weight adiponectin with risk of colorectal cancer: an observational study in Chinese male. Med Oncol. 2012;. doi:10.1007/s12032-012-0280-2.

    Google Scholar 

  19. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11(2 Pt 1):466–72.

    PubMed  CAS  Google Scholar 

  20. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, et al. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci. 2007;98(7):1120–7. doi:10.1111/j.1349-7006.2007.00486.x.

    Article  PubMed  CAS  Google Scholar 

  21. Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res. 2008;68(9):3178–84. doi:10.1158/0008-5472.CAN-08-0533.

    Article  PubMed  CAS  Google Scholar 

  22. Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism. 2011;60(9):1234–43. doi:10.1016/j.metabol.2011.01.005.

    Article  PubMed  CAS  Google Scholar 

  23. Cui E, Deng A, Wang X, Wang B, Mao W, Feng X, et al. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer. Biochem Cell Biol. 2011;89(3):308–13. doi:10.1139/O11-005.

    Article  PubMed  CAS  Google Scholar 

  24. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–5. doi:10.1093/bioinformatics/bth457.

    Article  PubMed  CAS  Google Scholar 

  25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75. doi:10.1086/519795.

    Article  PubMed  CAS  Google Scholar 

  26. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008;300(13):1523–31. doi:10.1001/jama.300.13.1523.

    Article  PubMed  CAS  Google Scholar 

  27. He B, Pan Y, Zhang Y, Bao Q, Chen L, Nie Z, et al. Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet. 2011;12:94. doi:10.1186/1471-2350-12-94.

    Article  PubMed  CAS  Google Scholar 

  28. Carvajal-Carmona LG, Spain S, Kerr D, Houlston R, Cazier JB, Tomlinson I. Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet. 2009;18(10):1889–92. doi:10.1093/hmg/ddp109.

    Article  PubMed  CAS  Google Scholar 

  29. Gornick MC, Rennert G, Moreno V, Gruber SB. Adiponectin gene and risk of colorectal cancer. Br J Cancer. 2011;105(4):562–4. doi:10.1038/bjc.2011.259.

    Article  PubMed  CAS  Google Scholar 

  30. Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011;43(12):1215–8. doi:10.1038/ng.978.

    Article  PubMed  CAS  Google Scholar 

  31. Feneberg A, Malfertheiner P. Epidemic trends of obesity with impact on metabolism and digestive diseases. Dig Dis. 2012;30(2):143–7. doi:10.1159/000336660.

    Article  PubMed  Google Scholar 

  32. Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci. 2008;53(3):597–605. doi:10.1007/s10620-007-9922-1.

    Article  PubMed  CAS  Google Scholar 

  33. Kang JH, Yu BY, Youn DS. Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci. 2007;22(1):117–21.

    Article  PubMed  CAS  Google Scholar 

  34. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA. 2004;101(8):2476–81.

    Article  PubMed  CAS  Google Scholar 

  35. Yamamoto N, Oshima T, Yoshihara K, Sato T, Yamada R, Fujii S, et al. Reduced expression of the AdipoR1 gene is correlated with venous invasion in colorectal cancer. Mol Med Report. 2009;2(4):555–9. doi:10.3892/mmr_00000136.

    Article  CAS  Google Scholar 

  36. Yamamoto S, Watabe K, Araki H, Kamada Y, Kato M, Kizu T, et al. Protective role of adiponectin against ethanol-induced gastric injury in mice. Am J Physiol Gastrointest Liver Physiol. 2012;302(8):G773–80. doi:10.1152/ajpgi.00324.2011.

    Article  PubMed  CAS  Google Scholar 

  37. de Moor CH, Meijer H, Lissenden S. Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin Cell Dev Biol. 2005;16(1):49–58. doi:10.1016/j.semcdb.2004.11.007.

    Article  PubMed  Google Scholar 

  38. Gui Y, Silha JV, Murphy LJ. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res. 2004;12(9):1481–91. doi:10.1038/oby.2004.185.

    Article  PubMed  CAS  Google Scholar 

  39. Sieminska L, Wojciechowska C, Niedziolka D, Marek B, Kos-Kudla B, Kajdaniuk D, et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism. 2005;54(12):1610–4. doi:10.1016/j.metabol.2005.06.008.

    Article  PubMed  CAS  Google Scholar 

  40. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280(18):18073–80. doi:10.1074/jbc.M414231200.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declared no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, School of Life Sciences, Anhui Medical University, Hefei, 230032, China

    Lei Ye, Wei-Dong Du, Yue Qiu, Yuan Zhou, Hong-Zhen Xia & Song Xu

  2. Department of Pathology, Anhui Medical University, Hefei, 230032, China

    Zuo-Yang Zhang & Ji-Feng Wu

  3. State Key Laboratory and Incubation Base of Dermatology of Ministry of National Science and Technology, Anhui Medical University, Meishan Road 81, Hefei, 230032, China

    Wei-Dong Du, Fu-Sheng Zhou, Xian-Bo Zuo, Gang Chen & Xue-Jun Zhang

  4. Sektion Experimentelle Anaesthesiologie, Universitaetsklinikum Ulm, 89081, Ulm, Germany

    Wei-Dong Du & Marion E. Schneider

  5. MVZ, ACURA Kliniken, 76530, Baden-Baden, Germany

    Xue-Ling Ma

  6. Clinical Laboratory, The First Affiliated Hospital, Anhui Medical University, Hefei, 230032, China

    Hong-Yuan Xu

Authors
  1. Lei Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zuo-Yang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei-Dong Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marion E. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yue Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuan Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fu-Sheng Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xian-Bo Zuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xue-Ling Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hong-Zhen Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Song Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Ji-Feng Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Hong-Yuan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Xue-Jun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei-Dong Du.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, L., Zhang, ZY., Du, WD. et al. Genetic analysis of ADIPOQ variants and gastric cancer risk: a hospital-based case–control study in China. Med Oncol 30, 658 (2013). https://doi.org/10.1007/s12032-013-0658-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0658-9

Keywords

Search

Navigation